DAX6.653-2,0%  Dow12.8910,1%  Euro1,3173-0,8% 
ESt502.473-2,0%  Nas2.9270,4%  Öl116,6-1,8% 
TDax769,7-0,5%  Nikkei8.947-0,6%  Gold1.711-1,1% 
Home > Aktien > EpiCept Aktie > Nachrichten zu EpiCept

EpiCept Aktie [WKN: A0EAY7 / ISIN: US2942642057]

Kurse + Charts + RealtimeNews + AnalysenFundamentalUnternehmenzugeh. WertpapiereAktion
Kurs + ChartChart (groß)News + AdhocBilanz/GuVTermineZertifikateDepot
Times + SalesChart-AnalyseAnalysenDividende/HVProfilOptionsscheineWatchlist
BörsenplätzeChartvergleichKursziele InsidertradesKnock-outsmyfinanzen
OrderbuchRealtime StuttgartRSS Feed im ForumFondsSenden
HistorischRealtime Push  IR-DatenAnleihen
handeln
Diese Aktie wird nicht mehr gehandelt

Hinweis

Auf dieser Seite finden Sie ALLE Nachrichten zur EpiCept CorpShs . Links ausgesuchte Top-Nachrichten, rechts weitere Meldungen.

Newssuche

 GO 

ALLE Nachrichten zur EpiCept CorpShs

14.01.10EpiCept Announces Reverse Split of Common Stock
14.01.10EpiCept Announces Executive Departure
11.01.10EpiCept Announces Commercial Licensing Agreement for Ceplene® with Meda in Europe and Pacific Rim
08.01.10EpiCept Announces Results of Special Meeting of Stockholders
07.01.10EpiCept to Present at OneMedPlace Finance Forum
15.12.09EpiCept Provides Clinical and Business Update on Ceplene Program
11.12.09EpiCept to Present at Lippert/Heilshorn & Associates Life Sciences Virtual Conference
24.11.09Notice of Special Meeting of Stockholders of EpiCept Corporation
10.11.09EpiCept Corporation Reports Third Quarter Results, Provides Business Update
09.11.09EpiCept Corporation Announces Health Canada Accepts Ceplene® Application for Review
06.11.09EpiCept Corporation Names Bernard Tyrrell as Senior Vice President, Sales and Marketing
05.11.09EpiCept to Report Third Quarter 2009 Operating and Financial Results on November 10, 2009
03.11.09Nasdaq Panel Grants EpiCept’s Request for Continued Listing
02.11.09EpiCept to Present at BIO-Europe 2009
26.10.09New Data Supports Pharmacoeconomic Benefits of Ceplene®
03.09.09EpiCept’s Ceplene® Highlighted in Two 2008 European Union Drug Approval Reports
02.09.09EpiCept Corporation to Present at the Rodman & Renshaw Healthcare Conference
06.08.09EpiCept Corporation Reports Second Quarter 2009 Operating and Financial Results, Provides Business Update
05.08.09EpiCept Announces Filing of New Drug Submission for Approval of Ceplene in Canada
03.08.09EpiCept to Report Second Quarter 2009 Operating and Financial Results on August 6, 2009
10.07.09EpiCept Initiates Post-Approval Clinical Study with Ceplene®
03.07.09EpiCept Announces Results of Annual Meeting of Stockholders
29.06.09EpiCept Shares on the OMX Nordic Exchange Transferred Back to Ordinary Position from Observation Segment
29.06.09EpiCept Shares on the OMX Nordic Exchange Transferred Back to Ordinary Position from Observation Segment
19.06.09EpiCept Announces Pricing of Public Offering
05.06.09EpiCept Corporation to Present at the 5th Annual Noble Financial Equity Conference
04.06.09EpiCept Releases New Data Demonstrating Long-Term Durability of Ceplene in Sustaining Leukemia-Free Survival
02.06.09EpiCept Partners With IDIS For Ceplene® Named Patient/Compassionate Use Program
29.05.09EpiCept Announces Webcast of Annual Meeting of Stockholders
28.05.09EpiCept Announces Presentation of New Crinobulin Data at 2009 American Society of Clinical Oncology Annual Meeting
07.05.09EpiCept Corporation Reports First Quarter 2009 Operating and Financial Results
01.05.09EpiCept to Report First Quarter 2009 Operating and Financial Results on May 7, 2009
30.04.09Notice of the Annual Meeting of Stockholders of EpiCept Corporation
13.04.09EpiCept Appoints Recognized Oncology Expert and Pharmaceutical Industry Leader as New Independent Board Member
27.02.09EpiCept Corporation Reports Fourth Quarter and Full Year 2008 Operating and Financial Results
24.02.09EpiCept to Report Fourth Quarter and Full Year 2008 Operating and Financial Results on February 27, 2009
23.02.09EpiCept Announces Debt Repayment
23.02.09EpiCept Announces EPC2407 Generic Name is Crinobulin
06.02.09EpiCept Corporation to Present at the 11th Annual BIO CEO & Investor Conference
05.02.09EpiCept Corporation Announces Pricing of Public Offering

Anzeige

ANZEIGE

 
Wie bewerten Sie diese Seite?
schlecht sehr gut
Aktien Prime Standard: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z DAX MDAX Dow Jones EuroStoxx

Kontakt - Impressum - Werben - Presse

finanzen.net als Startseite - Sitemap - Arbeiten bei finanzen.net - RSS-Feeds - Datenschutz - Disclaimer - Nutzungsbedingungen


Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Telekurs. Verzögerung Deutsche Börse: 15 Min., Nasdaq, NYSE: 20 Min. © 1999-2012 finanzen.net GmbH

News Aktien Kurslisten Analysen Devisen Dollarkurs Fonds Zertifikate Optionsscheine Anleihen Rohstoffe Aktien kaufen Portfolio Links Aktien China Währungsrechner Gold kaufen CFD Aktienkurse Ölpreis Leitzins Heizölpreis IPO Börsenkurse Lexikon